Healthcare Quarterly, 12(3) May 2009: 50-58.doi:10.12927/hcq.2013.20878
Costs of End-of-Life Care: Findings from the Province of Saskatchewan
As part of the Health Care Use at the End-of-Life in Western Canada Study, the Western Office of the Canadian Institute for Health Information (CIHI) collaborated with the ministries or departments of health in British Columbia, Alberta, Saskatchewan and Manitoba to highlight selected aspects of healthcare at the end of life. In-depth supplementary studies were also conducted for each of the four western provinces. Saskatchewan focused its analysis on healthcare costs in the two years before death. This article provides a summary of data on healthcare costs for persons who died in Saskatchewan in the 2003-2004 fiscal year. It is based on a more in-depth report prepared for CIHI and Saskatchewan Health titled "Final Report of the Saskatchewan End-of-Life Care Project." The full report can be freely accessed at www.hollanderanalytical.com. The CIHI reports can be accessed at http://secure.cihi.ca/cihiweb/dispPage.jsp? cw_page=PG_930_E&cw_topic=930 &cw_rel=AR_1729_E.
Detailed utilization data were obtained, on an anonymized basis, for the two-year period prior to death for Saskatchewan residents who died in Saskatchewan during the 2003-2004 fiscal year. An extensive set of edit and logic checks were used to clean the data.
Costs were standardized to fiscal 2003-2004 dollars; that is, the 2003-2004 unit costs were applied to the utilization rates, irrespective of the year in which services were used (except for physician services and drugs, where actual costs were used, resulting in a slight underestimate for these services). It should be noted that the administrative data did allow for a fairly complete accounting of total costs, including both the costs to government and the user fees paid by clients for such services. Income tested user fees were charged for long-term care facilities, home care services and drugs. User fees were actuals, or estimates, based on data provided by Saskatchewan Health. However, it should be noted that the data in this article do not include goods or services that were completely paid for by the individuals or their families (e.g., out of pocket expenses) or the imputed costs of unpaid caregiving. Thus, the term "total costs" in this article refers only to costs to government plus user fees paid by individuals or family members.
One of the important aspects of this project was that data were collected for the two-year period prior to death for the clients in the study. Most published reports present data on only one time period such as 30 days, six months or one year prior to death. In contrast, this article reports on four commonly referenced time periods prior to death: 30 days, 90 days, 180 days and 365 days.
The number of total individuals included in the analyses for the 30-, 90-, 180- and 365-day cohorts vary as not all people had medical coverage from Saskatchewan Health for the full two-year period prior to death. The total samples for each of the major cohorts in this project were as follows:
- 30-day cohort: 8,703
- 90-day cohort: 8,693
- 180-day cohort: 8,681
- 365-day cohort: 8,643
Using the full sample represented in the 30 days prior to death cohort, it was found that, overall, there were 4,292 females and 4,411 males. In terms of age, 16.4% of the sample was under 65, 46.3% was 65-84 and 37.3% were 85 years of age or older. For the interested reader, the full methods used in this study are detailed in the report prepared for CIHI and Saskatchewan Health.
It is important to note that this article focuses on end-of-life care, regardless of the context in which a person died. Thus, while some decedents received palliative care, the majority did not. This article does not analyze specific palliative care contexts or services.
There were some American studies on end-of-life care. Most of the studies analyzed Medicare costs. Scitovski (2005) noted two cautions that need to be considered when assessing end-of-life cost estimates from Medicare data. The first is that the data are limited to persons 65 years of age or older. The second, and major, caution is that the Medicare data sets do not include the majority of costs associated with nursing home care, resulting in an underestimate of costs.
The American literature varied in the cost estimates produced based on the year the study was conducted, the period prior to death that was analyzed, the type of condition leading to death, and other factors. Thus, it is not possible to derive a clear consensus estimate of current costs in the United States. On the low end of the cost spectrum, Liu et al. (2006) estimated a cost of US$40,000 for the year prior to death (in 1995) using both Medicare and Medicaid data. Similarly, Hoover et al. (2002) estimated an overall cost of US$37,581 for 1996 using Medicare data. At the higher end of the range, Lewin et al. (2005) studied patients who died from ovarian cancer. While their study compared hospice to non-hospice groups, the costs for non-hospice hospital care in the last 60 days of life was US$59,316. Daviglus et al. (2005) related costs in the last year of life to cardiovascular risk profiles earlier in the patients' lives. Depending on the risk profiles, annual Medicare costs (in 2002 dollars) ranged from US$86,908 for persons with low risk levels at baseline (1967-1973) to US$95,776 for people with four or more risk factors at baseline.
In an American study, which also relates to this article, Lunney et al. (2002) estimated costs for the groupings developed by Lunney and her colleagues. The costs for the last year of life for each of the Lunney groups for the mid-1990s were as follows:
- Sudden death: US$625
- Terminal illness: US$31,052
- Organ failure: US$36,834
- Frailty: US$24,849
- Other: US$9,225
With regard to Canadian data, perhaps the best known study is that of McGrail et al. (2000). Using British Columbia linked data sets that cover all major aspects of healthcare delivery, including long-term care facilities, the total costs of care in the last 6 months of life for people who died in 1993 (in 1995 dollars) ranged from $19,000 to $27,000, depending on age.
Key New Finding on the Impact of Residential Care in Determining End-of-Life Healthcare Costs
A major, and significant, finding of this study was that long-term care facility costs can have a profound impact on the costs of end-of-life care. For example, for people who were in long-term care facilities at the start of the six-month period prior to death, the average cost was $28,125, whereas the cost for people living independently in the community at the start of the period was $16,068. Thus, the influence of long-term care facility costs can be quite significant on any aggregate cost estimates, particularly if one looks at costs over a six-month to one-year period. The average costs of care also vary in relation to the relative proportion of people in a given study who are in long-term care facilities. To reflect the impact of residential long-term care, the data tables in this article show the impact on the costs of long-term care facilities.
Table 1 presents data on the costs to government and total costs for the 12 periods of 30 days prior to death. It presents overall costs, costs for individuals with no residential care and costs for people who were primarily in long-term care facilities. The grouping to which an individual was assigned was based on the patient's status at the beginning of the first 30-day period. As can be seen in Table 1, there is a significant difference in costs between individuals with and without residential long-term care. Overall, the average total cost per person, per 30-day period, was $2,639, ranging from $1,641 for the first of the 12 periods to $7,420 for the final 30-day period prior to death. The average cost, per 30-day period, for people with no residential care was $1,655, ranging from $613 to $8,087. The average cost for people who were primarily in residential care was $4,570 ranging from $4,543 to $5,260. As can be seen from Table 1, while average total costs per person increased significantly for all clients, and for clients without residential care, for the better part of the 12-month period, the costs for clients in long-term care facilities were relatively consistent, reflecting the lower level of use of other health services, such as hospitals, at the end of life. It should also be noted that there is a large discrepancy in the total cost figure, and the cost to government figure, for people in long-term care facilities compared with the other two groups. This difference is due to user fees charged for facility care.
Costs Related to Socio-demographic Characteristics
Overall, except for the costs for the 30-day period prior to death, the average total costs for females were higher than those for males. Thus, while the average total cost for males and females were $7,581 and $7,236, respectively, for the 30 days prior to death, the costs for the 365 days prior to death were $28,649 for males and $35,306 for females. However, this appears to be an artifact related to the higher proportion of females in long-term care facilities.
There was a clear progression in which costs were increasingly higher in accordance with age for the period of 365 days prior to death. However, this was not the case for the other time periods. While costs increased across all time periods for persons aged 19-44, 45-64 and 65-74, they tended to be lower for the 75-84 and 85+ age groups than for the 65-74 age group for the 30-, 90- and 180-day time periods. There were also different patterns of costs across the four time periods by marital status, although the lowest costs across all four time periods were for people who were single, divorced or separated. For the 365-day period, the costs for persons who were widowed were significantly higher ($37,030) than for those who were married or living in common law relationships ($28,699). (The marital status differentials also appear to be related to the higher use of long-term care facilities by the higher-cost groups.)
Costs Related to the Context of the Client
As noted above, the context of care has a great deal to do with the costs incurred at the end of life. Table 2 presents data for each of the time periods in our analysis, that is, the 30, 90, 180 and 365 days prior to death. For each time period, the table notes the distribution of costs depending on the context of the client at the start of the period - in facility, in hospital, in the community with home care or in the community without home care. For each time period, the highest cost was for people who started the time period in the hospital. For the 30- and 90-day periods, the next highest cost group was people living in the community with home care. Most of the costs for this group were related to hospital care.
For the 180- and 365-day groups, the second highest cost was for people in a long-term care facility. What is also interesting, and quite significant, is that the facility care group had consistently lower costs for other parts of the healthcare system. The major cost for people in facilities is the cost of facility care. This is similar to findings by Hollander (2001) in regard to administrative data for British Columbia. The majority of costs for community-living individuals who die is for hospital care.
Costs Related to the Lunney/Fassbender Groupings
In any end-of-life care study, it is important to be able to group individuals into clusters of relatively like individuals for purposes of analysis and comparison. For example, if one combined people who had a sudden death (e.g., in an automobile accident) with those who had a serious chronic illness, the resulting average would be a statistical artifact that represented neither of these groups and could not readily be used for planning or costing purposes.
In the Health Care at the End-of-Life in Western Canada Study, it was decided to use a grouping approach developed by Lunney and her colleagues (2002, 2003). This grouping is used in the current report as well. Table 3 presents the names and descriptions of what are referred to as the Lunney/Fassbender Causes of Death Trajectory Groupings. This terminology is used as Fassbender et al. (2006) adapted the methodology for calculating group membership to the Canadian context.
|Table 3. Cause of death trajectory groupings|
|Name of Grouping||Description|
|Sudden death (e.g., accidental death, falls, trauma)||Decedents in this group are likely to be in good health or to display normal functional ability before the incident that causes death. While it is possible that a condition associated with one of the groups below is present, the underlying cause of death is one of trauma, accident or other unintended causes. Typically, these decedents display low healthcare costs relative to the other groups.|
|Terminal illness (e.g., cancer, chronic renal failure, HIV-related diseases)||Typically, decedents in this group diagnosed with some form of cancer in the last year of life show substantial physician billings for cancer-related treatment. Functional status information demonstrates a terminal phase for this group. Typically, these decedents demonstrate a short period of evident decline.|
|Organ failure (e.g., congestive heart failure, COPD)||Organ failure decedents are typically diagnosed with either CHF or COPD. Decedents in this group are likely to experience long-term limitations, exacerbated by acute episodes (with high costs or long hospitalizations) followed by recovery. Episode severity may gradually increase, while post-episode recoveries lessen, eventually leading to death.|
|Frailty (e.g., neurological decline and other frequent causes of death among the elderly)||Typically, due to their advanced age, decedents in this category may display lower functional status relative to other decedents in the year before death. The pattern of decline over time is typically more gradual, characterized as prolonged dwindling.|
|Other (e.g., those not elsewhere categorized)||These are the remaining decedents whose conditions are not classified into any of the other four categories and may not exhibit specific patterns in functional decline or service utilization.|
|CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; HIV = human immunodeficiency virus.
Sources: Data from Fassbender et al. (2006); Lunney et al. (2002, 2003).
Table 4 presents data for the five Lunney/Fassbender groupings. It is interesting to note that for the period 30 days prior to death, the highest cost factor for all groupings was hospital care, the next highest was residential long-term care and the third highest was physician services. This pattern changed over time. For the period 365 days prior to death for frailty, organ failure, and other, the highest cost factor was residential long-term care. The clear exception to this pattern was terminal illness, for which hospital care was, by far, the most significant cost factor across all time periods.
Costs for the Five Most Common Causes of Death
A wide range of causes of death were analyzed for this project. Table 5 presents the relative cost distributions, across types of healthcare services and time before death, for the five most common causes of death (in rank order). There are also interesting patterns of costs for the five main causes of death. For the 30 days prior to death, with one exception, the primary cost factor is hospital care. The exception is death due to diseases of the nervous system and sense organs, for which the highest cost was residential long-term care. This could be related to people in long-term care facilities suffering from dementia. For the period 365 days prior to death, the major cost factor for neoplasms was hospital care. For the deaths due to diseases of the circulatory system, the respiratory system and the nervous system and sense organs, the major cost factor was residential long-term care.
Costs for Persons Receiving Palliative Care
Table 6 presents a comparison of people identified as having received palliative care. All clients identified as part of Saskatchewan's palliative drug program and all clients with a palliative care indicator for a hospital stay were characterized as palliative care clients. There were a total of 2,250 such clients. It is interesting to note that the average total cost per client was less for people who were identified as having received palliative care than for people who did not receive palliative care, except for the group 365 days prior to death. The difference between the two groups appears to diminish in proportion to the length of the period prior to death. This is understandable as most palliative care programs are designed for people near the end of life. One clear finding from the data presented in Table 6 is the relatively lower cost for hospital care for palliative clients across all time periods. This is a significant finding. However, as this was not a study of the cost-effectiveness of palliative care per se, further research is indicated to determine the relative cost-effectiveness of palliative care services.
It is believed that this study represents one of a relatively few major studies conducted in Canada on the costs of end-of-life care. Future research in other jurisdictions could begin to paint a more complete picture on the costs of end-of-life care in Canada.
This study has pointed out a major new finding related to the relative influence of long-term care facilities on the average cost of end-of-life care. As can be seen from this report, the influence on costs of persons receiving long-term residential care is significant and increases over time. Thus, the relative proportion of people in facilities can impact end-of-life costing for a given geographical entity such as a regional health authority. For example, if all other conditions are identical across two regional health authorities but the proportion of people who are in long-term care facilities prior to death differs, the overall costs also tend to differ. Thus, when making cost comparisons, one needs to control for the impact of facility care across geographical entities such as health authorities, provinces or countries. It is recommended that, in future, researchers clearly show costs separately for people living at home and people living in long-term care facilities as part of their analyses.
Finally, in terms of overall costs, the estimated total healthcare costs for people who died, for the four time periods, in fiscal 03/04 and 09/10 dollars, for Saskatchewan and Canada as a whole are presented in Table 7.
|Table 7. Cost Estimates for fiscal 2003/04 and 2009/10 for people who died: Saskatchewan and Canada|
|Time Period||Total Costs (in million $) for Saskatchewan||Extrapolated Costs (in million $) for Canada|
|Fiscal* 2003-2004||Fiscal† 2009-2010||Fiscal* 2003-2004||Fiscal† 2009-2010|
|* Extrapolations to Canada for Fiscal 03/04 are based on population estimates for people aged 65 years of age or older. The Canadian population 65+ was 27.8 times as great as the Saskatchewan population 65+, as of December 2003. Thus, Saskatchewan costs were multiplied by 27.8 to obtain the fiscal 03/04 cost estimates for Canada.
† The extrapolations from fiscal 03/04 to fiscal 09/10 were based on cost increases in Saskatchewan for services related to end-of-life care, that is, regional services, medical services (fee-for-service and non-fee-for-service cost only) and costs for drugs and extended benefits (prescription drug plan and aids to independent living only). This represented an increase of 62.1% from fiscal 03/04 to fiscal 09/10. This increase was applied to the fiscal 03/04 estimated costs for Saskatchewan and Canada to obtain the fiscal 09/10 estimates. The figures for Canada for fiscal 09/10 are deemed to be an underestimate as the population aged 65+ increased at a faster rate in Canada than in Saskatchewan, between fiscal 03/04 and fiscal 09/10.
From the data in Table 7, one can see that total healthcare costs (costs to government and user fees) for people who died in fiscal year 2003-2004 extrapolated to Canada ranged from $1.7 billion for the 30 days prior to death to $6.8 billion for the one-year period prior to death. The comparable figures for fiscal 09/10 were $2.8 billion and $11 billion.
About the Author
Marcus J. Hollander, PhD, is the president of Hollander Analytical Services Ltd., a national health services and policy research company, headquartered in Victoria, British Columbia. You can contact him at 250-384-2776, by fax at 250-389-0105 or by e-mail at email@example.com.
The author would like to acknowledge CIHI and Saskatchewan Health for providing funding for this project. He would also like to thank the staff and management of these organizations for their assistance and support. The author would like to acknowledge the contribution of Angela Tessaro for programming related to the complex administrative data analyzed for this project. Finally, he would also like to acknowledge the contribution of Nicole Littlejohn and Kathy Fyfe for their assistance in preparing the original report.
This study is based on de-identified data provided by the Saskatchewan Department of Health. The interpretation and conclusions contained herein do not necessarily represent those of the government of Saskatchewan, Saskatchewan Health or CIHI.
Daviglus, M.L., K. Liu, A. Pirzadam, L.L. Yan, D.B. Garside, P. Greenland, L.M. Manheim, A.R. Dyer, R. Wang, J. Lubitz, W.G. Manning, J.F. Fries and J. Stamler. 2005. "Cardiovascular Risk Profile Earlier in Life and Medicare Costs in the Last Year of Life." Archives of Internal Medicine 165: 1028-34.
Fassbender, K., J.G. Smythe, M. Carson, B.A. Finegan and P.M. Boothe. 2006. Costs and Utilization of Health Care Services at End-of-life. Report of the Institute for Public Economics Health Research Group to Alberta Health and Wellness. Edmonton, AB: Institute for Public Economics.
Hollander, M.J. 2001. Substudy 1: Final Report of the Study on the Comparative Cost Analysis of Home Care and Residential Care Services. Victoria, BC: National Evaluation of the Cost-Effectiveness of Home Care.
Hoover, D.R., S. Crystal, R. Kumar, U. Sambamoorthi and J.C. Cantor. 2002. "Medical Expenditures during the Last Year of Life: Findings from the 1992-1996 Medicare Current Beneficiary Survey." Health Services Research 37(6): 1625-42.
Lewin, S.N., B.M. Buttin, M.A. Powell, R.K. Gibb, J.S. Rader, D.G. Mutch and T.J. Herzog. 2005. "Resource Utilization for Ovarian Cancer Patients at the End of Life: How Much Is Too Much?" Gynecologic Oncology 99: 261-66.
Liu, K., J.M. Wiener and M.R. Niefeld. 2006. "End of Life Medicare and Medicaid Expenditures for Dually Eligible Beneficiaries." Health Care Financing Review 24(4): 95-110.
Lunney, J., J. Lynn, D. Foley, S. Lipson and J. Guralnik. 2003. "Patterns of Functional Decline at the End of Life." Journal of the American Medical Association 289(18): 2387-92.
Lunney, J.R., J. Lynn and C. Hogan. 2002. "Profiles of Older Medicare Decedents." Journal of the American Geriatrics Society 50: 1108-12.
McGrail, K., B. Green, M.L. Barer, R.G. Evans, C. Hertzman and C. Normand. 2000. "Age, Costs of Acute and Long-Term Care and Proximity to Death: Evidence for 1987-88 and 1994-95 in British Columbia." Age Ageing 29(3): 249-53.
Scitovski, A.A. 2005. "The High Cost of Dying: What Do the Data Show?" Milbank Quarterly 83(4): 825-41.
Be the first to comment on this!Please Sign In or Create an Account to add comments